• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma


51.7700 USD 0.2600 0.50%

As of 13:58:58 ET on 10/01/2014.

Snapshot for Hospira Inc (HSP)

Open: 52.0300 Day's Range: 51.3000 - 52.0900 Volume: 360,981
Previous Close: 52.0300 52wk Range: 38.1100 - 56.7800 1-Yr Rtn: +30.44%

Stock Chart for HSP

No chart data available.
  • HSP:US 51.7700
  • 1D
  • 1M
  • 1Y
Interactive HSP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HSP

Current P/E Ratio (ttm) 28.2010
Estimated P/E(12/2014) 21.5618
Relative P/E vs. SPX 1.5762
Earnings Per Share (USD) (ttm) 1.8347
Est. EPS (USD) (12/2014) 2.4010
Est. PEG Ratio 1.6571
Market Cap (M USD) 8,730.18
Shares Outstanding (M) 168.73
30 Day Average Volume 818,759
Price/Book (mrq) 2.6836
Price/Sale (ttm) 2.0140
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HSP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HSP

Hospira, Inc. is a global pharmaceutical and medication delivery company that develops, manufactures and markets products. The Company's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products. Hospira products are used by hospitals, clinics, home healthcare providers and long-term care facilities.

F Michael Ball "Mike"Chief Executive OfficerDavid John EndicottPres:Medical Devices
Daphne E JonesSenior VP/CIOBrian J SmithSenior VP/Chief Legal Officer
More Company Profile & Key Executives for HSP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil